[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:proprotein-convertase-subtilisin-kexin-type-9":3},{"name":4,"total":5,"trials":6},"Proprotein Convertase Subtilisin\u002FKexin Type 9",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07477704","A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia",[11],"Phase 2","RECRUITING","2026-08-03T02:52:04.574589Z","2026-06-14T18:39:22.242897Z"]